Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
2(33%)

Phase Distribution

Ph phase_1
3
50%
Ph phase_3
2
33%
Ph not_applicable
1
17%

Phase Distribution

3

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
3(50.0%)
Phase 3Large-scale testing
2(33.3%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(3)
Terminated(2)
Other(1)

Detailed Status

Completed3
Terminated2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
60.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (50.0%)
Phase 32 (33.3%)
N/A1 (16.7%)

Trials by Status

unknown117%
completed350%
terminated233%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_1

A Study of JNJ-74856665 in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

NCT04609826
completedphase_3

Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis

NCT03096275
completedphase_1

A Study of ARGX-110 in Combination With Azacytidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) or High Risk Myelodysplatic Syndrome (MDS)

NCT03030612
terminatedphase_1

Safety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

NCT02319369
terminatedphase_3

Efficacy of Infliximab in the Treatment of Patients Affected by Corticodependent Crohn's Disease (P02732)

NCT00796250
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04609826Phase 1

A Study of JNJ-74856665 in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Completed
NCT03096275Phase 3

Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis

Completed
NCT03030612Phase 1

A Study of ARGX-110 in Combination With Azacytidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) or High Risk Myelodysplatic Syndrome (MDS)

Completed
NCT02319369Phase 1

Safety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Terminated
NCT00796250Phase 3

Efficacy of Infliximab in the Treatment of Patients Affected by Corticodependent Crohn's Disease (P02732)

Terminated
NCT00997412Not Applicable

Trial of Mycophenolic Acid Versus Azathioprine in the Treatment of Corticosteroid-refractory Myasthenia Gravis

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6